China NMPA Drug Inspection - Chifeng Sailintai Pharmaceutical Co., Ltd. - Compound Acetylsalicylic Acid Tablets
China NMPA drug inspection for Chifeng Sailintai Pharmaceutical Co., Ltd. published November 28, 2019. Drug: Compound Acetylsalicylic Acid Tablets. The Hubei Provincial Drug Administration issued its third Drug Quality Announcement of 2019 on November 28, 2019, detail
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Chifeng Sailintai Pharmaceutical Co., Ltd. published November 28, 2019. Drug: Compound Acetylsalicylic Acid Tablets. The Hubei Provincial Drug Administration issued its third Drug Quality Announcement of 2019 on November 28, 2019, detail
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox